Calibrate

Providing GLP-1 coverage? A smart step! But if you want to create a lasting impact, it’s crucial to go beyond medication and empower your employees with lifestyle intervention. Imagine increased energy, sharper focus, improved time management, and greater self-confidence—all driving higher productivity and employee satisfaction. Curious how? Explore our latest article on the power of combining GLP-1 with lifestyle intervention. Your employees—and your ROI—will thank you! https://hubs.la/Q02WNY0D0… #EmployeeEngagement #Workplace #HealthAndWellness

We’re excited to unveil the results from our second research poster at #ObesityWeek2024. This poster demonstrates how Calibrate supports members in achieving a BMI of less than 25. 4 key takeaways:  1️⃣ Healthy BMI Achievement: In just 12 months, 13.5% of Calibrate members reached a BMI below 25, the benchmark for reduced metabolic risk factors. 2️⃣ Remarkable Weight Loss & Waist Reduction: Members who achieved a healthy BMI lost an average of 24.2% of their body weight and reduced their waist circumference by 7.64 inches by month 12. 3️⃣ Metabolic Health Gains: These members showed statistically significant improvements in HbA1c, LDL Cholesterol, Triglycerides, ALT, AST, hs-CRP, and insulin—driving meaningful health impact. 4️⃣ Program Engagement: Members reaching a healthy BMI were significantly more engaged in the program, consistently tracking and attending coaching sessions. These findings underscore how Calibrate’s structured approach supports sustainable, measurable health improvements. Stay tuned for more in our 2025 Results Report! #ObesityWeek #GLP1 #WeightManagement #HealthInnovation #MetabolicHealth #DigitalHealth #ProveIt

Adding GLP-1 coverage to your benefits package is a great move, but the true game-changer? Lifestyle intervention. By incorporating sustainable changes to nutrition, sleep, exercise, and emotional health, employees can significantly improve their outcomes—and your company’s bottom line. The difference? Weight loss outcomes leap from 3% to as high as 18% with the right support. Explore why lifestyle intervention is the key to driving long-term success in our newest article! https://hubs.la/Q02W-_t90... #EmployeeWellness #SustainableResults #LongTermSuccess

Originally created for diabetes management, GLP-1 medications are proving to be multi-purpose powerhouses, showing benefits for cancer risk reduction, cardiovascular health, and beyond. But, as our experts discuss in #RadioAdvisory’s latest podcast episode from HLTH USA 2024, their impact can be maximized only with a holistic approach. Join Rachel Woods, our CEO Rob MacNaughton, Real Chemistry's Rita Glaze-Rowe, and Spencer Nadolsky, DO as they reveal why combining GLP-1s with lifestyle interventions is the key to unlocking their full potential. Listen to the episode now to understand where this field is headed: https://lnkd.in/eSPgFsgP #GLP1s #TransformativeHealth #Podcast #RadioAdvisory #HLTHUSA #ProveIt

GLP-1 medications are transforming the approach to weight loss, but the full picture goes beyond the prescription. For employers offering GLP-1 coverage, there’s a crucial piece to consider: lifestyle intervention. Real-world evidence shows that combining GLP-1s with 1:1 coaching and intensive lifestyle changes boosts success rates by 16-18%! Why stop at medication when comprehensive support can lead to healthier, longer-lasting outcomes for your workforce? Read our latest article to learn how lifestyle intervention elevates employee health and delivers stronger business returns. https://hubs.la/Q02X1zSt0... #EmployeeWellness #Benefits #SustainableResults #Employer

With #Thanksgiving just around the corner, Calibrate employees are embracing the spirit of giving back! Our team had the privilege of recording storybooks to support children’s comprehension and to bring joy to kids in need. Working with Ronald McDonald House Charities, we helped create a series of audiobooks to comfort and entertain children undergoing medical treatment. These stories and poems aim to ease fear, reduce anxiety, and bring a little extra warmth to each child’s experience. Making a meaningful difference in someone’s day means the world to us, and we’re grateful for every opportunity to share a moment of #kindness! #wellness #Calibrategiveback #thankful

Calibrate is thrilled to be recognized by Daniel Drucker, an esteemed scientist and endocrinologist at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital in Toronto. Dr. Drucker has made groundbreaking contributions to our understanding and use of GLP-1 medication, which have enabled the development of new classes of medications for the treatment of diabetes, obesity, and obesity-associated comorbidities. We appreciate Dr. Drucker’s support of our recently published poster presented at ObesityWeek® 2024. See the full post: https://lnkd.in/eNqQfR-v #ObesityWeek #GLP1 #ScientificPoster #MetabolicHealth

New Podcast Alert! In a special episode of #RadioAdvisory, recorded live from HLTH USA 2024, host Rachel Woods dives deep into the promise and challenges of GLP-1 medications. She’s joined by our Calibrate CEO Rob MacNaughton, Real Chemistry's Rita Glaze-Rowe, and Spencer Nadolsky, DO to tackle a question everyone’s asking: What can’t GLP-1s do? From cardiovascular benefits to potential in weight management, these experts explore both the optimism and the limitations surrounding GLP-1s. This conversation is a must-listen for anyone following the latest in healthcare innovation! Tune in now to get the full insights: https://lnkd.in/eSPgFsgP #GLP1s #HealthInnovation #RadioAdvisory #HLTHUSA #ProveIt #Podcast

ObesityWeek® is in full swing, and it’s been an incredible experience so far! Being here, surrounded by so many passionate leaders and innovators, reaffirms just how impactful our work in obesity care can be. I’m thrilled to be presenting alongside Calibrate's data scientist, Kaelen Medeiros, and sharing some of our most promising results. 📊 Key findings we’re highlighting: SUSTAINED WEIGHT LOSS OUTCOMES: Our program has enabled members to achieve lasting weight reduction of 15.7% at 12 months, 17.2% at 24 months, and 18.1% at 36 month, along with improvements in metabolic markers like lipids, HbA1c, LFTs, hs-CRP, and insulin. GLP-1 DISCONTINUATION SUCCESS: Our data shows there are some members who are able to maintain significant weight loss, with over 10% sustained at 52 weeks post-discontinuation. ACHIEVING A HEALTHY BMI: We’re proud that 13.5% of members reached a healthy BMI (under 25) within just 12 months, demonstrating the power of a comprehensive metabolic health program. It’s been inspiring to connect with others who share our vision for advancing obesity treatment and improving lives. If you’re here at Obesity Week, I’d love to connect and keep the conversation going! Stop by our poster today from 2:30-3:30pm CST. #ObesityWeek #OW2024 #MetabolicHealth #SustainableWeightLoss #Calibrate #GLP1 #ObesityTreatment

Exciting news! Calibrate’s CEO, Rob MacNaughton, recently joined Clint Betts on the CEO.com podcast to share Calibrate's mission and pioneering approach to sustainable weight loss. Here are a few key insights from the conversation: - Anti-obesity medications aren’t a magic pill. While powerful, the real transformation happens when these medications are combined with Calibrate's clinician-led lifestyle intervention and coaching platform. - At Calibrate, we think of obesity as the center pin in a game of bowling. Knocking the center pin down significantly impacts a range of other health conditions, improving overall outcomes and reducing healthcare costs. - Our results? They speak for themselves—members lost 16% of their body weight in the first year and 18% by year two—surpassing results from medication alone. Check out a full recap of the conversation on our blog to learn more about how Calibrate is charting a path toward improved metabolic health and sustainable weight loss: https://lnkd.in/ejCnntPt #CEO #Healthcare #ClinicalResults #Podcast #Obesity